510(k) Report

510(k) · Cleared

Cleared

Velogene Rapid Mrsa Identification Assay

K990640510(k) TraditionalCleared Jul 9, 1999133-day reviewClass II21 CFR 866.1640

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Id Biomedical Corp. · MYI System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies

Cleared on Jul 9, 1999 after a 133-day review. The FDA summary names its predicate without a number.

Decided
Jul 9, 1999
Review
133 days
Class
Class II
Product code
MYI
Recalls
None
Predicates
0

The FDA summary names its predicate without a number.

FIG. 1 — Lineage of K990640Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MYI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Oxacillin Screen Agar
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All MYI devices

MYI System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MYI

2in 2014

2010: 22012: 12014: 2
2007high 2 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MYI

Too few MYI 510(k)s in any year since 2007 to give a median.

Recalls per year · MYI

No recall names MYI since 2007.

Adverse event reports per year · MYI

2in 2023

2023: 2
2007high 2 (2023) · low 0 (2007)2025

MAUDE reports naming product code MYI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20102—00
20110—00
20121—00
20130—00
20142—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—02
20240—00
20250—00
20260—0—

What is it indicated for?

The ID Biomedical Velogene™ Rapid MRSA Identification Assay is a qualitative DNA probe test which utilizes Cycling Probe™ Technology (CPT) to detect the mecA gene in isolated colonies of presumptively identified Staphylococcus aureus.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K990640: Velogene Rapid Mrsa Identification Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K990640

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026